On August 28, 2019, leading experts in cancer immunotherapy presented the latest advances in cancer immunotherapy emerging from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting.
The webinar summarized key studies on the following topics:
- Biomarkers and checkpoint inhibitors
- Cellular therapies
- First-line and neoadjuvant studies
Webinar attendees also had the opportunity to interact with the leading experts during a dedicated question-and-answer session.
James L. Gulley, MD, PhD, FACP – National Cancer Institute
Kim A. Margolin, MD – City of Hope
Ahmand Tarhini, MD, PhD – Moffitt Comprehensive Cancer Center
August 28, 2019